The Secret of Entering The Automated Assembly Trend

The Secret of Entering The Automated Assembly Trend

Obamacare and Europe’s economic situation are exerting significant cost pressures on Medical Devices. Leading manufacturers are meeting these pressures with semi and full automation, even at their low-cost locations. The benefits are clear, cutting the total process length and training costs can massively affect costs. Executing manual processes automatically reduces risks and is more robust. Yet for businesses who wish to jump on this wagon, and automate their assembly line or part of it, a few considerations should be taken into account.

Successfully automating assembly processes, either in products or in Custom Integrated Components (CIC), requires a knowledgeable and professional design, preferably as part of the product design stage and by a partner with experience in the area. Thorough process design includes characterizing and choosing the right method of automation. The automation should be considered through all processes with value and can include electromechanical assembly, coiling and micro assembly, packaging, raw material cutting and stripping, laser soldering and welding,  and the like, combining the right portion of automation to human elements in the process.  With an efficient design of the process, a medical device business can harvest the power of automation and robotics, maximizing cost effective benefits.

Quasar group, with 3 decades of experience in medical device manufacturing, has implemented the most advanced automation methods already in its core assembly capabilities. We already run production lines combining human and automatic processes, whether in manufacturing, in AOI (Automatic Optical Inspection) or in the packaging stages. We now do micro assembly under 10 micron and have automated the adhesive placement process, both amount and location. We further implemented an automated vision and measurement process in product qualification process. We support these new operational skills with professional process design services, and minimize the uncertainty in the planning stage.

Our customers benefit hugely from these capabilities. As partners in the design process, we plan for and execute production with fixed duration and high consistency.  The 10,000th product that  emerges is identical to and  the same quality as the first product, allowing us to provide the highest levels of performance to our clients, saving on months of training and operating at the highest efficiency.

social position

More news

Quasar’s new top-technology production facility

We are happy to announce the opening of our new manufacturing facility in Dongguan, China. The facility is now in the validation phase and will fully operational for mass production during Q1-2018. The new facility is our newest asset in our effort to deliver higher quality and newer technologies for innovative medical device mass production and process-design services.

Quasar passes FDA inspection with no 483 findings

An FDA audit was conducted from October 31 to November 3 at the Quasar manufacturing facility in Shenzhen. This is the second consecutive audit Quasar has passed, by the FDA, and the result with NO findings in non-conformance (no 483) endorses Quasar’s renewed commitment to being a qualified medical device manufacturer. Consistent with Quasar’s legacy of maintaining high quality standards, quality is focused on throughout the entire production process, starting from development, and maintained through all phases to manufacturing.